Skip to main content
. 2021 Jan 20;13(3):372. doi: 10.3390/cancers13030372

Table 2.

Z’ factor of phospho-c-Met intensity between high and low concentration in each inhibitor.

Target Drug Name Z’ factor Summary 1
c-Met Ab SAIT301 0.35 *
c-Met Inhibitor Carbozantinib 0.97 **
Crizotinib 0.67 **
Fretinib 0.75 **
Capmatinib 0.12 *
CDK4/6 Inhibitor Abemaciclib 0.59 **
Palbociclib −0.34 ns 2
Ribociclib −2.54 ns

1 1 ≥ ** > 0.5 ≥ * >0 ≥ ns. 2 ns; not significant.